Takinib

(Synonyms: EDHS-206)
30 Cited Publications
Revisión del cliente

Based on 30 publication(s) in Google Scholar

Takinib (EDHS-206) is an orally active and selective TAK1 inhibitor (IC50=9.5 nM), more than 1.5 log more potent than the second and third ranked targets, IRAK4 (120 nM) and IRAK1 (390 nM), respectively. Takinib is an inhibitor of autophosphorylated TAK1 that non-competitively binds within the ATP binding pocket. Takinib induces apoptosis following TNFα stimulation in cell models of rheumatoid arthritis and metastatic breast cancer. Takinib is also a P. falciparum protein kinase 9 (PfPK9) inhibitor (KD(app) of 0.46 μM).

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.48%
  • No. CAS: 1111556-37-6
  • Fòrmula: C18H18N4O2
  • Peso molecular:322.36
  • Almacenamiento:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 1 year , -20°C, 6 months
  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Pureza y Documentación
  • Referencias
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Takinib

More
Customer Validation & Images
WBBio/Physico-chemical AssayRT-PCR
  • Bio/Physico-chemical Assay
  • Bio/Physico-chemical Assay
  • WB
  • RT-PCR
  • WB
  • WB

Ver todos los productos específicos de isoformas MAP3K

More
100 mg

Obtener un presupuesto En stock

Please select quantity
Amount: USD 0.00